Dermatology · Terre Haute, IN
NPI
1124414388
Since 2015
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2133 S State Road 46
Terre Haute, IN, 47803
Phone (812) 244-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
3,695 services
Medicare patients, 2024
1,004
Average age 74
Drug cost, 2024
$3.2M
1,573 prescriptions
Company payments, 2025
$9,475
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by June C Kunapareddy was code 17003 (destruction skin lesion), 1,169 times for 266 patients. In total June C Kunapareddy billed 3,695 services in 42 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,169 | 266 | $4.12 | $4,822 |
| 99213 Office E&M - Established | Office | 755 | 593 | $58.47 | $44K |
| 17000 Destruction Skin Lesion | Office | 429 | 374 | $36.82 | $16K |
| 99214 Office E&M - Established | Office | 266 | 220 | $82.80 | $22K |
| 11102 Skin Biopsy | Office | 230 | 203 | $60.90 | $14K |
| 99203 Office E&M - New | Office | 221 | 221 | $68.82 | $15K |
| 99204 Office E&M - New | Office | 92 | 92 | $108.41 | $9,974 |
| 17110 Destruction Skin Lesion | Office | 87 | 81 | $67.49 | $5,872 |
| 99212 Office E&M - Established | Office | 63 | 61 | $38.91 | $2,451 |
| 11103 Skin Biopsy | Office | 35 | 31 | $31.33 | $1,097 |
| 96372 Injection Administration | Office | 35 | 11 | $9.76 | $341 |
| 99202 Office E&M - New | Office | 33 | 33 | $49.94 | $1,648 |
| 17262 Destruction Skin Lesion | Office | 31 | 28 | $117.39 | $3,639 |
| 11105 Skin Biopsy | Office | 24 | 14 | $41.32 | $992 |
| 69100 Other Organ Systems | Office | 20 | 20 | $50.59 | $1,012 |
By year: 2022 $139K for 2,977 services; 2023 $154K for 3,750 services; 2024 $157K for 3,695 services.
Medicare prescription drug claims, 2024
In 2024, the drug June C Kunapareddy prescribed most often to Medicare patients was Ketoconazole, with 190 prescriptions and refills. In total June C Kunapareddy wrote 1,573 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 190 | 201 | 95 | $3,842 |
| Triamcinolone Acetonide Generic | 178 | 197 | 112 | $1,641 |
| Clobetasol Propionate Generic | 134 | 137 | 83 | $6,081 |
| Tacrolimus Generic | 122 | 126 | 53 | $21K |
| Fluorouracil Generic | 115 | 121 | 94 | $9,530 |
| Dutasteride Generic | 76 | 119 | 13 | $1,315 |
| Cosentyx Unoready Pen Secukinumab | 72 | 72 | 11 | $701K |
| Hydroxyzine Hcl Generic | 71 | 90 | 25 | $657 |
| Skyrizi Pen Risankizumab-Rzaa | 55 | 145 | 15 | $1.1M |
| Dupixent Pen Dupilumab | 55 | 55 | Under 11 | $200K |
| Terbinafine Hcl Generic | 53 | 65 | 19 | $367 |
| Clindamycin Phosphate Generic | 44 | 44 | 15 | $1,861 |
| Metronidazole Generic | 37 | 39 | 22 | $2,272 |
| Nystatin Generic | 29 | 29 | 15 | $215 |
| Mycophenolate Mofetil Generic | 25 | 34 | Under 11 | $2,267 |
Brand drugs: 388 claims; generic drugs: 1,185 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid June C Kunapareddy $9,475 ($9,475 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $8,804.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $8,804 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $262 |
| Janssen Biotech, Inc. JNJ | 11 | $239 |
| UCB, Inc. UCB.BR | 2 | $35.15 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $31.96 |
| Pfizer Inc. PFE | 1 | $23.03 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $19.16 |
| Genzyme Corporation SNY | 1 | $15.96 |
| Cycle Pharmaceuticals Inc | 1 | $14.74 |
| Lilly USA, LLC LLY | 1 | $14.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.